ArticleAnnals of medicine2023

Outcomes of thymoglobulin versus basiliximab induction therapies in living donor kidney transplant recipients with mild to moderate immunological risk - a retrospective analysis of UNOS database.

Hatem Ali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.